Comparisons · FAQ
Semaglutide vs tirzepatide: What is the main difference?
Short answer
Semaglutide acts on GLP-1 receptors, while tirzepatide acts on both GLP-1 and GIP receptors. These signals help control appetite and blood sugar. Weekly injections of either drug may support weight management in eligible adults. Results vary. A physician licensed in your state decides which treatment, if any, is appropriate.
Semaglutide and tirzepatide act on hormone signals that help manage appetite and blood sugar. Semaglutide targets GLP-1 receptors. Tirzepatide targets both GLP-1 and GIP receptors. Both also slow the movement of food through the stomach, especially early in treatment.
Weekly injectable products containing these drugs are used for weight management in eligible adults. They are used with changes in eating habits and physical activity. Both may help with weight loss, but neither guarantees a certain result. Results vary.
The added GIP action does not mean tirzepatide is the right choice for everyone. Your health history, other medicines, side effects, treatment goals, and access all matter. Semaglutide also comes in oral products, but tablets and injections have different directions and product-specific approved uses.
At Verra, a physician licensed in your state reviews your health information before deciding whether treatment is appropriate. If a compounded medication is prescribed, it is prepared by a licensed pharmacy for one patient and is not FDA-approved.
Sources
Written by the Verra clinical team · Medical review pending
General information, not medical advice. If you're in crisis, call or text 988.
Related guides
Related questions
- Semaglutide vs tirzepatide: Which leads to more weight loss?
- Semaglutide vs tirzepatide: Who may qualify for weight management treatment?
- Semaglutide vs tirzepatide: How do side effects compare?
- Semaglutide vs tirzepatide: How do weekly injections and oral options differ?
- Semaglutide vs tirzepatide: How long does it take to notice changes?